Current Cancer Drug Targets
Volume 20, 11 Issues, 2020
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
  |
In the current Pandemic scenario, all articles related to Coronavirus will be processed on a quick track basis, to ensure timely review and publication of much needed research
Contents
Current Cancer Drug Targets, Volume 12 - Number 9
Editorial
mTOR as a Potential Target for the Prevention and Treatment of Hepatocellular Carcinoma
, 12(9): 1045 - 1061Laura Elisa Buitrago-Molina and Arndt Vogel
DOI: 10.2174/15680096112091045
Non-Coding RNAs as Therapeutic Targets in Hepatocellular Cancer
, 12(9): 1073 - 1080Chiara Braconi and Tushar Patel
DOI: 10.2174/15680096112091073
Cancer Stem Cell as a Potential Therapeutic Target in Hepatocellular Carcinoma
, 12(9): 1081 - 1094Roberta W.C. Pang and Ronnie T.P. Poon
DOI: 10.2174/15680096112091081
Angiogenesis in Hepatocellular Carcinoma: A Potential Target for Chemoprevention and Therapy
, 12(9): 1095 - 1118Anupam Bishayee and Altaf S. Darvesh
DOI: 10.2174/15680096112091095
Role of Acyclic Retinoid in the Chemoprevention of Hepatocellular Carcinoma: Basic Aspects, Clinical Applications, and Future Prospects
, 12(9): 1119 - 1128Masahito Shimizu, Kenji Imai, Koji Takai and Hisataka Moriwaki
DOI: 10.2174/15680096112091119
Prevention of Hepatocellular Carcinoma: Potential Targets, Experimental Models, and Clinical Challenges
, 12(9): 1129 - 1159Yujin Hoshida, Bryan C. Fuchs and Kenneth K. Tanabe
DOI: 10.2174/15680096112091129
Chemoprevention of Hepatocarcinogenesis with Dietary Isoprenic Derivatives: Cellular and Molecular Aspects
, 12(9): 1173 - 1190Thomas Prates Ong, Monica Testoni Cardozo, Aline de Conti and Fernando Salvador Moreno
DOI: 10.2174/15680096112091173
Dietary Phytochemicals in the Chemoprevention and Treatment of Hepatocellular Carcinoma: In Vivo Evidence, Molecular Targets, and Clinical Relevance
, 12(9): 1191 - 1232Anupam Bishayee, Roslin J. Thoppil, Abhijeet Waghray, Jaclyn A. Kruse, Nicholas A. Novotny and Altaf S. Darvesh
DOI: 10.2174/15680096112091191
Anti-tumor Efficacy of a Recombinant Human Arginase in Human Hepatocellular Carcinoma
, 12(9): 1233 - 1243Ariel K.M. Chow, Lui Ng, Hung Sing Li, Chi Wai Cheng, Colin S.C. Lam, Thomas C.C. Yau, Paul N.M. Cheng, Sheung Tat Fan, Ronnie T.P. Poon and Roberta W.C. Pang
DOI: 10.2174/15680096112091233
Black Currant Anthocyanins Abrogate Oxidative Stress through Nrf2- Mediated Antioxidant Mechanisms in a Rat Model of Hepatocellular Carcinoma
, 12(9): 1244 - 1257Roslin J. Thoppil, Deepak Bhatia, Kendra F. Barnes, Erzsebet Haznagy-Radnai, Judit Hohmann, Altaf S. Darvesh and Anupam Bishayee
DOI: 10.2174/15680096112091244
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
View Full Editorial Board
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
View Full Editorial Board
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.75
Advertisement
Webmaster Contact: info@benthamscience.net